| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6500454 | ANI PHARMS | Timed, sustained release systems for propranolol |
Oct, 2021
(2 years ago) | |
Innopran Xl is owned by Ani Pharms.
Innopran Xl contains Propranolol Hydrochloride.
Innopran Xl has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Innopran Xl are:
- US6500454
Innopran Xl was authorised for market use on 12 March, 2003.
Innopran Xl is available in capsule, extended release;oral dosage forms.
The generics of Innopran Xl are possible to be released after 04 October, 2021.
Drugs and Companies using PROPRANOLOL HYDROCHLORIDE ingredient
Market Authorisation Date: 12 March, 2003
Treatment: NA
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
More Information on Dosage
INNOPRAN XL family patents
